<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants - Aher, SM - 2020 | Cochrane Library</title> <meta content="Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants - Aher, SM - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004865.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants - Aher, SM - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004865.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004865.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" name="citation_title"/> <meta content="Sanjay M Aher" name="citation_author"/> <meta content="Neocare Hospital" name="citation_author_institution"/> <meta content="ahersm@googlemail.com" name="citation_author_email"/> <meta content="Arne Ohlsson&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004865.pub4" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/02/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004865.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004865.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004865.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia, Neonatal [blood, prevention &amp; control]; Epoetin Alfa; Erythrocyte Transfusion [*statistics &amp; numerical data]; Erythropoietin [*administration &amp; dosage, adverse effects, blood]; Infant, Low Birth Weight [*blood]; Infant, Premature [*blood]; Randomized Controlled Trials as Topic; Retinopathy of Prematurity [blood, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004865.pub4&amp;doi=10.1002/14651858.CD004865.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="QO4KtYGW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004865\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004865\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ja","fa","ms","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004865.pub4",title:"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants",firstPublishedDate:"Feb 11, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004865.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004865.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004865.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004865.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004865.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004865.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004865.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004865.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004865.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004865.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5218 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004865.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0061"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0055"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-sec-0060"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/table_n/CD004865StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/table_n/CD004865StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information#CD004865-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sanjay M Aher</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information#CD004865-cr-0003">Arne Ohlsson</a><sup>a</sup></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information/en#CD004865-sec-0069">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 February 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004865.pub4">https://doi.org/10.1002/14651858.CD004865.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004865-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004865-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004865-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004865-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004865-abs-0002">日本語</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004865-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004865-abs-0001" lang="en"> <section id="CD004865-sec-0001"> <h3 class="title" id="CD004865-sec-0001">Background</h3> <p>Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anaemia. </p> </section> <section id="CD004865-sec-0002"> <h3 class="title" id="CD004865-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of early versus late initiation of EPO in reducing red blood cell (RBC) transfusions in preterm and/or low birth weight (LBW) infants. </p> </section> <section id="CD004865-sec-0003"> <h3 class="title" id="CD004865-sec-0003">Search methods</h3> <p>The standard search of the Cochrane Neonatal Review Group (CNRG) was performed in 2006 and updated in 2009. Updated search in September 2009 as follows: <i>The Cochrane Library</i>, MEDLINE (search via PubMed), CINAHL and EMBASE were searched from 2005 to September 2009. The searches were repeated in March 2012. The Pediatric Academic Societies' Annual meetings were searched electronically from 2000 to 2012 at Abstracts2View<sup>TM</sup> as were clinical trials registries (clinicaltrials.gov; controlled‐trials.com; and who.int/ictrp). </p> </section> <section id="CD004865-sec-0004"> <h3 class="title" id="CD004865-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials enrolling preterm or LBW infants less than eight days of age. Intervention: Early initiation of EPO (initiated at less than eight days of age) versus late initiation of EPO (initiated at eight to 28 days of age). </p> </section> <section id="CD004865-sec-0005"> <h3 class="title" id="CD004865-sec-0005">Data collection and analysis</h3> <p>The standard methods of the CNRG were followed. Weighted treatment effects included typical risk ratio (RR), typical risk difference (RD), number needed to treat to benefit (NNTB), number needed to treat to harm (NNTH) and mean difference (MD), all with 95% confidence intervals (CI). A fixed‐effect model was used for meta‐analyses and heterogeneity was evaluated using the I‐squared (I<sup>2</sup>) test. </p> </section> <section id="CD004865-sec-0006"> <h3 class="title" id="CD004865-sec-0006">Main results</h3> <p>No new trials were identified in March of 2012. Two high quality randomised double‐blind controlled studies enrolling 262 infants were identified. A non‐significant reduction in the 'Use of one or more RBC transfusions' [two studies 262 infants; typical RR 0.91 (95% CI 0.78 to 1.06); typical RD ‐0.07 (95% CI ‐0.18 to 0.04; I<sup>2</sup> = 0% for both RR and RD] favouring early EPO was noted. Early EPO administration resulted in a non‐significant reduction in the "number of transfusions per infant" compared with late EPO [typical MD ‐ 0.32 (95% CI ‐0.92 to 0.29)]. There was no significant reduction in total volume of blood transfused per infant or in the number of donors to whom the infant was exposed. Early EPO led to a significant increase in the risk of retinopathy of prematurity (ROP) (all stages) [two studies, 191 infants; typical RR 1.40 (95% CI 1.05 to 1.86); typical RD 0.16 (95% CI 0.03 to 0.29); NNTH 6 (95% CI 3 to 33)]. There was high heterogeneity for this outcome (I<sup>2</sup> = 86% for RR and 81% for RD). Both studies (191 infants) reported on ROP stage &gt; 3. No statistically significant increase in risk was noted [typical RR 1.56 (95% CI 0.71 to 3.41); typical RD 0.05 (‐0.04 to 0.14)] There was no heterogeneity for this outcome (0% for both RR and RD). No other important favourable or adverse neonatal outcomes or side effects were reported. </p> </section> <section id="CD004865-sec-0007"> <h3 class="title" id="CD004865-sec-0007">Authors' conclusions</h3> <p>The use of early EPO did not significantly reduce the 'Use of one or more RBC transfusions' or the 'Number of transfusions per infant" compared with late EPO administration. The finding of a statistically significant increased risk of ROP (any grade) and a similar trend for ROP stage &gt; 3 with early EPO treatment is of great concern. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004865-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004865-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004865-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004865-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004865-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004865-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004865-abs-0012">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004865-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004865-abs-0004" lang="en"> <h3>Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants </h3> <p>The number of red blood cells falls after birth in preterm infants due to the natural breakdown of erythrocytes and blood letting. Low levels of erythropoietin (EPO), a substance in the blood that stimulates red blood cell production in preterm infants, provide a rationale for the use of EPO to prevent or treat anaemia. A total of 262 infants born preterm have been enrolled in two studies of early versus late administration of EPO to prevent blood transfusions. There were no demonstrable benefits of early versus late administration of EPO with regards to reduction in the use of red blood cell transfusions, number of transfusions, the amount of red cells transfused or number of donor exposures per infant. However, the use of early EPO compared with late EPO administration increases the risk of retinopathy of prematurity, a serious complication in babies born before term. Currently, there is a lack of evidence that either treatment confers any substantial benefits with regard to any donor blood exposure, as many infants enrolled in both studies were exposed to donor blood prior to study entry, and early EPO increases the risk of retinopathy of prematurity. Neither early nor late administration of EPO is recommended. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004865-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004865-sec-0061"></div> <h3 class="title" id="CD004865-sec-0062">Implications for practice</h3> <section id="CD004865-sec-0062"> <p>Currently there is a lack of evidence that early EPO confers any substantial benefits compared with late administration of EPO, particularly with regard to any donor blood exposure, as a large proportion of infants enrolled in both studies were exposed to donor blood prior to study entry. There is a concern of an increased risk of ROP following early administration of EPO, and such treatment is not recommended. </p> </section> <h3 class="title" id="CD004865-sec-0063">Implications for research</h3> <section id="CD004865-sec-0063"> <p>The impact of either early or late administration of EPO on 'any donor exposure' is likely to be minimal, as many infants would have been exposed to donor blood during the first few days of life, when they are most likely to receive a red blood cell transfusion; a time period during which EPO treatment could not possibly prevent donor exposure. Any ongoing study of EPO should carefully monitor the incidence of ROP and data/safety monitoring committees should be informed of its occurrence. Further studies to compare early versus late administration of EPO are not justified. Research should focus on reducing blood letting and the use of satellite packs from the same donor, should red blood cell transfusions be necessary. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004865-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004865-sec-0029"></div> <section id="CD004865-sec-0030"> <h3 class="title" id="CD004865-sec-0030">Description of the condition</h3> <p>The haemoglobin concentration falls to minimal levels of 11 g/dL in term infants by eight to 12 weeks of age and 7.0 to 10.0 g/dL in preterm infants by six weeks of age (<a href="./references#CD004865-bbs2-0022" title="StockmanJA3rd , OskiFA . Physiological anaemia of infancy and the anaemia of prematurity. Clinics in Hematology1978;7:3‐18. ">Stockman 1978</a>). This process is called physiologic anaemia of infancy (<a href="./references#CD004865-bbs2-0024" title="StraussRG . Current issues in neonatal transfusions. Vox Sanguinis1986;51:1‐9. ">Strauss 1986</a>). In very low birth weight (VLBW) infants, the haematocrit falls to approximately 24% in infants weighing 1.0 to 1.5 kg and to 21% in infants weighing less than 1.0 kg at birth (<a href="./references#CD004865-bbs2-0023" title="StockmanJA3rd . Anemia of prematurity. Current concept in the issue of when to transfuse. Pediatric Clinics of North America1986;33:111‐28. ">Stockman 1986</a>). In extremely low birth weight (ELBW) infants, this decline in haematocrit is not "physiologic", as it is associated with clinical findings that prompt red blood cell transfusions. The diagnostic accuracy of different clinical signs and laboratory findings has not been studied. It is still unknown how low haematocrit levels can fall before clinical signs of anaemia of prematurity occur and what is the minimal haematocrit level acceptable in infants requiring supplemental oxygen (<a href="./references#CD004865-bbs2-0017" title="OhlsRK . Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. Journal of Pediatrics2002;141:3‐6. ">Ohls 2002</a>). Nevertheless, "top‐up" transfusions to treat low haemoglobin or low haematocrit levels are frequently used. As many as 80% of VLBW infants and 95% of ELBW infants receive blood transfusions during their hospitalisations (<a href="./references#CD004865-bbs2-0027" title="WidnessJA , SewardVJ , KromerIJ , BurmeiserLF , BellEF . Changing patterns of red blood cell transfusion in very low birth weight infants. Journal of Pediatrics1996;129:680‐7. ">Widness 1996</a>). </p> </section> <section id="CD004865-sec-0031"> <h3 class="title" id="CD004865-sec-0031">Description of the intervention</h3> <p>Erythropoietin (EPO) and iron effectively stimulate erythropoiesis. Plasma erythropoietin levels in neonates are lower than those for older children and adults. Brown and colleagues reported that, between days two and 30 of life, the mean EPO concentration was 10 mLU/mL, as compared to 15 mLU/mL in concurrently studied adults (<a href="./references#CD004865-bbs2-0005" title="BrownMS , PhibbsRH , GarciaJF , DallmanPR . Postnatal changes in erythropoietin levels in untransfused premature infants. Journal of Pediatrics1983;103:612‐7. ">Brown 1983</a>). A low plasma EPO level is a key reason that nadir haematocrit values of preterm infants are lower than those of term infants (<a href="./references#CD004865-bbs2-0023" title="StockmanJA3rd . Anemia of prematurity. Current concept in the issue of when to transfuse. Pediatric Clinics of North America1986;33:111‐28. ">Stockman 1986</a>; <a href="./references#CD004865-bbs2-0006" title="DallmanPR . Anemia of prematurity. Annual Review of Medicine1981;32:143‐60. ">Dallman 1981</a>). Low plasma EPO levels provide a rationale for use of EPO in the prevention or treatment of anaemia of prematurity. Studies in newborn monkeys and sheep have demonstrated that neonates have a large volume of distribution and more rapid elimination of EPO, necessitating the use of higher doses than required for adults (<a href="./references#CD004865-bbs2-0016" title="OhlsRK . The use of erythropoietin in neonates. Clinics in Perinatology2000;27:681‐96. ">Ohls 2000</a>). A systematic review of EPO administration noted a wide range of doses used, from 90 to 1400 IU/kg/week (<a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). Side effects reported in adults include hypertension, bone pain, rash and rarely seizures. Only transient neutropenia has been reported in neonates (<a href="./references#CD004865-bbs2-0016" title="OhlsRK . The use of erythropoietin in neonates. Clinics in Perinatology2000;27:681‐96. ">Ohls 2000</a>). </p> </section> <section id="CD004865-sec-0032"> <h3 class="title" id="CD004865-sec-0032">How the intervention might work</h3> <p>The primary goal of EPO therapy is to reduce transfusions. Most transfusions are given during the first three to four weeks of life. The larger or stable preterm infants, who respond best to EPO, receive few transfusions. ELBW infants, who are sick and have the greatest need for red blood cell (RBC) transfusions shortly after birth, have not consistently responded to EPO. This suggests that EPO is a more effective erythropoietic stimulator in more mature neonates. ELBW neonates are more likely to need transfusions even if their erythropoiesis is stimulated (<a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). In addition, ELBW neonates have a smaller blood volume and the relatively larger phlebotomy volumes that are required during hospital stay often necessitate "early" transfusions. In contrast "late" transfusions are more often given because of anaemia of prematurity (<a href="./references#CD004865-bbs2-0009" title='GarciaMG , HutsonAD , ChristensenRD . Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta‐analysis. Journal of Perinatology2002;22:108‐11. '>Garcia 2002</a>). Most preterm infants who require blood transfusions will receive their first transfusion in the first two weeks of life (<a href="./references#CD004865-bbs2-0029" title="ZipurskyA . Erythropoietin therapy for premature infants: cost without benefit?. Pediatric Research2000;48:136. ">Zipursky 2000</a>). Reducing the number of RBC transfusions reduces the risk of transmission of viral infections and may reduce costs. Frequent RBC transfusions may be associated with retinopathy of prematurity (ROP) (<a href="./references#CD004865-bbs2-0011" title="HesseL , EberlW , SchlaudM , PoetsCF . Blood transfusion. Iron load and retinopathy of prematurity. European Journal of Pediatrics1997;156:465‐70. ">Hesse 1997</a>) and bronchopulmonary dysplasia (BPD). </p> <p>Preterm infants need iron for erythropoiesis. As neonatal blood volume expands with rapid growth, infants produce large amounts of haemoglobin. Several studies have observed a decrease in serum ferritin concentration ‐ an indication of iron deficiency (<a href="./references#CD004865-bbs2-0008" title="FinchCA . Erythropoiesis, erythropoietin and iron. Blood1982;60:1241‐6. ">Finch 1982</a>) ‐ during EPO treatment. The use of higher, more effective doses of EPO might be expected to be particularly likely to increase iron demand and the risk of iron deficiency (<a href="./references#CD004865-bbs2-0010" title="GenenLH , KlenoffH . Iron supplementation for erythropoietin‐treated preterm infants. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD003061.pub2] ">Genen 2004</a>). Iron supplementation during EPO treatment has been observed to reduce the risk of the development of iron deficiency (<a href="./references#CD004865-bbs2-0021" title="ShannonKM , KeithJF3rd , MentzerWC , EhrenkranzRA , BrownMS , WidnessJA , et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight infants. Pediatrics1995;95:1‐8. ">Shannon 1995</a>). The range of iron doses used in EPO treated infants is between 1 mg/kg/day to 10 mg/kg/day (<a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). </p> </section> <section id="CD004865-sec-0033"> <h3 class="title" id="CD004865-sec-0033">Why it is important to do this review</h3> <p>The efficacy of EPO in anaemia of prematurity has recently been systematically reviewed (<a href="./references#CD004865-bbs2-0025" title="VamvakasEC , StraussRG . Meta‐analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion2001;41:406‐15. ">Vamvakas 2001</a>; <a href="./references#CD004865-bbs2-0009" title='GarciaMG , HutsonAD , ChristensenRD . Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta‐analysis. Journal of Perinatology2002;22:108‐11. '>Garcia 2002</a>; <a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). Vamvakas et al concluded that there is extreme variation in the results, and until this variation is better understood, it is too early to recommend EPO as standard treatment for the anaemia of prematurity (<a href="./references#CD004865-bbs2-0025" title="VamvakasEC , StraussRG . Meta‐analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion2001;41:406‐15. ">Vamvakas 2001</a>). Garcia et al concluded that administering EPO to VLBW neonates can result in a modest reduction in late erythrocyte transfusions and that this effect is dependent on the dose of EPO used (<a href="./references#CD004865-bbs2-0009" title='GarciaMG , HutsonAD , ChristensenRD . Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta‐analysis. Journal of Perinatology2002;22:108‐11. '>Garcia 2002</a>). Kotto‐Kome et al concluded that if EPO is begun in the first week of life, a moderate reduction can be expected in the proportion of VLBW neonates transfused. The reduction is less significant for early transfusion than for late transfusion (<a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). </p> <p>Additional studies of EPO in preterm or LBW infants have been published since the reviews noted above, justifying additional reviews. The cut‐off of less than eight days of age for early and &gt; eight days for late treatment with EPO, although somewhat arbitrary, was chosen based on previously published meta‐analyses (<a href="./references#CD004865-bbs2-0009" title='GarciaMG , HutsonAD , ChristensenRD . Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta‐analysis. Journal of Perinatology2002;22:108‐11. '>Garcia 2002</a>; <a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>). </p> <p>This review compares early administration of EPO (starting in infants less than eight days of age) versus late administration of EPO (starting &gt; eight days). The main rationale for this review was to evaluate whether early treatment with EPO in preterm infants is more effective than late treatment to decrease exposure to RBC transfusion and the total transfusions required. We performed a systematic review to compare all available studies where EPO was begun during first week of life versus EPO started after the first week of life to assess the effect on any and total number of erythrocyte transfusions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004865-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004865-sec-0034"></div> <section id="CD004865-sec-0035"> <h3 class="title" id="CD004865-sec-0035">Primary objective:</h3> <p>To assess the effectiveness and safety of early (before eight days after birth) versus late (between eight to 28 days after birth) initiation of EPO in reducing the need for red blood cell transfusions in preterm and/or low birth weight infants. </p> <p><b>Subgroup analyses:</b><br/> We planned subgroup analyses within this review for low (&lt; 500 IU/kg/week) and high (&gt; 500 IU/kg/week) doses of EPO, and low (&lt; 5 mg/kg/day) and high (&gt; 5 mg/kg/day) doses of supplemental iron administered by any route. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004865-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004865-sec-0036"></div> <section id="CD004865-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004865-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised or quasi‐randomised controlled trials.</p> </section> <section id="CD004865-sec-0039"> <h4 class="title">Types of participants</h4> <p>Preterm (&lt; 37 weeks) and/or low birth weight (&lt; 2500 g) neonates less than eight days of age. </p> </section> <section id="CD004865-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Early initiation of EPO (initiated before eight days of age, using any dose, route or duration) versus late initiation of EPO (initiated between eight to 28 days of age, using any dose, route or duration). </p> </section> <section id="CD004865-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD004865-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004865-list-0001"> <li> <p>Use of one or more red blood cell (RBC) transfusions.</p> </li> </ol> </p> </section> <section id="CD004865-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004865-list-0002"> <li> <p>the total volume (mL/kg or mL/kg/day) of RBCs transfused per infant;</p> </li> <li> <p>number of transfusions per infant;</p> </li> <li> <p>number of donors to whom the infant was exposed;</p> </li> <li> <p>mortality during initial hospital stay (all causes);</p> </li> <li> <p>retinopathy of prematurity (ROP) (any stage and stage &gt; 3);</p> </li> <li> <p>proven sepsis (clinical symptoms and signs of sepsis and positive blood culture for bacteria or fungi); </p> </li> <li> <p>necrotising enterocolitis (NEC) (Bell's stage II or more);</p> </li> <li> <p>intraventricular haemorrhage (IVH); all grades and severe IVH (grades III and IV);</p> </li> <li> <p>periventricular leukomalacia (PVL); cystic changes in the periventricular areas;</p> </li> <li> <p>length of hospital stay;</p> </li> <li> <p>bronchopulmonary dysplasia (BPD) (supplemental oxygen at 28 days of age or at 36 weeks postmenstrual age and compatible X‐ray); </p> </li> <li> <p>sudden infant death (SID) after discharge;</p> </li> <li> <p>long‐term outcomes assessed at any age beyond one year of age by a validated cognitive, motor, language, or behavioural/school/social interaction/adaptation test; </p> </li> <li> <p>neutropenia;</p> </li> <li> <p>any side effects reported in the trials.</p> </li> </ol> </p> </section> </section> </section> <section id="CD004865-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004865-sec-0045"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Central Register of Controlled Trials (CENTRAL, <i>The Cochrane Library</i>, 2006, Issue 2) was searched to identify relevant randomised and quasi‐randomised controlled trials. MEDLINE was searched for relevant articles published from 1966 to November 2005 using the following MeSH terms or text words: (exp Erythropoietin/OR erythropoietin:.mp. OR rhuepo.mp.) AND (anaemia/OR exp anaemia, neonatal/) AND (blood transfusion/OR blood component transfusion/OR erythrocyte transfusion/) AND (infant, newborn/OR infant, low birth weight/OR infant, very low birth weight/OR infant, premature/OR exp Infant, Premature, Diseases) OR (neonate: OR prematur*: OR newborn:).mp. OR newborn infant [age limit]) AND (clinical trial.pt. OR Randomized Controlled Trials/OR (random: OR rct OR rcts OR blind OR blinded OR placebo:).mp. OR (review.pt. OR review, academic.pt.) AND human. EMBASE from 1980 to November 2005 and CINAHL 1982 to November 2005 using the following MeSH terms or text words: (Erythropoietin/OR erythropoietin: OR epo OR epogen OR epoetin: OR (rhuepo).mp. AND (anaemia/OR exp anaemia, neonatal/) AND (blood transfusion/OR exp blood component transfusion/OR erythrocytes/) AND exp Infant, Premature, Diseases/OR infant, newborn/OR infant, low birth weight/OR infant, very low birth weight/OR infant, premature/OR (neonate: OR newborn: OR prematur*:).mp. OR newborn infant [age limit]. </p> <p>In September 2009, we updated the search as follows: <i>The Cochrane Library</i>, MEDLINE (search via PubMed), CINAHL and EMBASE were searched from 2005 to September 2009. </p> <p>Search terms: <i>erythropoietin</i> OR <i>rhuepo</i> AND <i>anaemia</i> OR <i>anaemia</i> AND <i>blood transfusion</i> OR <i>blood component transfusion</i> OR <i>erythrocyte transfusion</i> . Limits: human, infant and clinical trial. No language restrictions were applied. Clinicaltrials.gov was also searched with no date restriction. Search terms: <i>Erythropoietin</i> OR <i>rhuepo</i> AND <i>infant.</i> </p> <p>In March 2012, we updated the searches as per above. In addition we searched clinical trials registries (clinicaltrials.gov; controlled‐trials.com; and who.int/ictrp). </p> </section> <section id="CD004865-sec-0046"> <h4 class="title">Searching other resources</h4> <p>In addition to the electronic searches, manual searches of bibliographies and personal files were performed. No language restrictions were applied. </p> <p>Abstracts published from the Pediatric Academic Societies' Meetings and the European Society of Pediatric Research Meetings (published in <i>Pediatric Research</i>) were handsearched from 1980 to April 2006. </p> <p>In May 2012 abstracts from the Pediatric Academic Societies' Annual Meetings were searched electronically at Abstracts2View<sup>TM</sup> from 2000 to 2012. </p> </section> </section> <section id="CD004865-sec-0047"> <h3 class="title" id="CD004865-sec-0047">Data collection and analysis</h3> <p>The standard review methods of the Cochrane Neonatal Review Group and the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004865-bbs2-0013" title="HigginsJPT , GreenS . Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. The Cochrane Collaboration, 2011. ">Higgins 2011</a>) were used. </p> <section id="CD004865-sec-0048"> <h4 class="title">Selection of studies</h4> <p>For the original review, both review authors assessed all abstracts and published studies identified as potentially relevant by the literature search for inclusion in the review. </p> </section> <section id="CD004865-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>For the original review, each review author extracted data separately on a data abstraction form. The information was then compared and differences were resolved by consensus. One review author (AO) entered data into RevMan 5.1 (<a href="./references#CD004865-bbs2-0020" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>) and the other (SA) cross checked the printout against his own data abstraction forms and any errors were corrected. We planned that for any studies identified only as abstracts, we would contact the primary author to obtain further information. </p> </section> <section id="CD004865-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For the original review, the quality of included trials was evaluated independently by the review authors, using the following criteria:<br/> Blinding of randomisation; Blinding of intervention; Blinding of outcome measure assessment; Completeness of follow‐up. There are three potential answers to these questions yes, no, cannot tell. This information was added to the <a href="./references#CD004865-sec-0075" title="">Characteristics of included studies</a> table. </p> <p>For the update in 2012, the following issues were evaluated and entered into the 'Risk of bias' table. </p> <p><b>Selection bias</b> (random sequence generation and allocation concealment). </p> <p>For each included study, we categorised the risk of selection bias as:</p> <p><i>Random sequence generation</i> </p> <p>Low risk ‐ adequate (any truly random process e.g. random number table; computer random number generator);<br/> <br/> High risk ‐ inadequate (any non random process e.g. odd or even date of birth; hospital or clinic record number);<br/> <br/> Unclear risk ‐ no or unclear information provided. </p> <p><i>Allocation concealment</i> </p> <p>For each included study, we categorised the risk of bias regarding allocation concealment as: </p> <p>Low risk ‐ adequate (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);<br/> <br/> High risk ‐ inadequate (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth);<br/> <br/> Unclear risk ‐ no or unclear information provided </p> <p><b>Performance bias</b> </p> <p>For each included study, we categorised the methods used to blind study personnel from knowledge of which intervention a participant received. (As our study population consisted of neonates they would all be blinded to the study intervention). </p> <p>Low risk ‐ adequate for personnel (a placebo that could not be distinguished from the active drug was used in the control group); </p> <p>High risk ‐ inadequate ‐ personnel aware of group assignment;</p> <p>Unclear risk ‐ no or unclear information provided.</p> <p><b>Detection bias</b> </p> <p>For each included study, we categorised the methods used to blind outcome assessors from knowledge of which intervention a participant received. (As our study population consisted of neonates they would all be blinded to the study intervention). Blinding was assessed separately for different outcomes or classes of outcomes. We categorised the methods used with regards to detection bias as: </p> <p>Low risk ‐ adequate; follow‐up was performed with assessors blinded to group assignment;<br/> <br/> High risk ‐ inadequate; assessors at follow‐up were aware of group assignment;<br/> <br/> Unclear risk ‐ no or unclear information provided </p> <p><b>Attrition bias</b> </p> <p>For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we re‐included missing data in the analyses. We categorised the methods with respect to the risk attrition bias as:<br/> <br/> Low risk ‐ adequate (&lt; 10% missing data);<br/> <br/> High risk ‐ inadequate (&gt; 10% missing data);<br/> <br/> Unclear risk ‐ no or unclear information provided. </p> <p><b>Reporting bias</b> </p> <p>For each included study, we described how we investigated the risk of selective outcome reporting bias and what we found. We assessed the methods as: </p> <p>Low risk ‐ adequate (where it is clear that all of the study's pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> <p>High risk ‐ inadequate (where not all the study's pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> <p>Unclear risk ‐ no or unclear information provided (the study protocol was not available).</p> <p><b>Other bias</b> </p> <p>For each included study, we described any important concerns we had about other possible sources of bias (for example, whether there was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data‐dependent process). We assessed whether each study was free of other problems that could put it at risk of bias as:<br/> <br/> Low risk ‐ no concerns of other bias raised;<br/> <br/> High risk ‐ concerns raised about multiple looks at the data with the results made known to the investigators, difference in number of patients enrolled in abstract and final publications of the paper;<br/> <br/> Unclear ‐ concerns raised about potential sources of bias that could not be verified by contacting the authors. </p> <p>If needed, we planned to explore the impact of the level of bias through undertaking sensitivity analyses. </p> <p>For the original review, independent quality assessments were conducted by two review authors (SA, AO), who were not blinded to authors, institution or journal of publication. </p> <p>The update in 2012 was conducted by one author (AO).</p> </section> <section id="CD004865-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>Statistical analyses were performed using Review Manager software (RevMan 5.1) (<a href="./references#CD004865-bbs2-0020" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). Categorical data were analysed using risk ratio (RR), risk difference (RD), number needed to treat to benefit (NNTB) or number needed to harm (NNTH) for dichotomous outcomes and mean difference (MD) for continuous data. The 95% Confidence interval (CI) was reported on all estimates. </p> </section> <section id="CD004865-sec-0052"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity between trials by inspecting the forest plots and quantifying the impact of heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD004865-bbs2-0012" title="HigginJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. British Medical Journal2003;327:557‐60. ">Higgins 2003</a>). We used the following criteria for describing the percentages of heterogeneity; &lt; 25% no heterogeneity, &gt; 25% to 49% low heterogeneity, 50% to 74% moderate heterogeneity and &gt; 75% high heterogeneity. If we detected statistical heterogeneity, we planned to explore the possible causes (for example, differences in study quality, participants, intervention regimens, or outcome assessments) using <i>post hoc</i> subgroup analyses if possible. </p> </section> <section id="CD004865-sec-0053"> <h4 class="title">Data synthesis</h4> <p>The analysis was performed using RevMan5.1 (<a href="./references#CD004865-bbs2-0020" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). For estimates of typical RR and RD, we used the Mantel‐Haenszel method. For measured quantities, we used the inverse variance method. All meta‐analyses were done using the fixed‐effect model. </p> </section> <section id="CD004865-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned subgroup analyses within this review for low (&lt; 500 IU/kg/week) and high (&gt; 500 IU/kg/week) doses of EPO, and low (&lt; 5 mg/kg/day) and high (&gt; 5 mg/kg/day) doses of supplemental iron administered by any route. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004865-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004865-sec-0055"></div> <section id="CD004865-sec-0056"> <h3 class="title">Description of studies</h3> <p>The update in 2012 did not identify any additional studies. Two studies enrolling 268 infants were identified (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>; <a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>). For details of the studies see table <a href="./references#CD004865-sec-0075" title="">Characteristics of included studies</a>. One non randomised study was excluded (<a href="./references#CD004865-bbs2-0003" title="RudzinskaIM , KornackaMK , PawluchR . Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity [Leczenie preparatami ludzkiej rekombinowanej erytropoetyny a czeztosc retinopatii u noworodkow przedwczesnie urodzonych (Polish)]. Prezglad Lekarski2002;59 Supplement 1:83‐5. ">Rudzinska 2002</a>). For transfusion guidelines see Additional table (<a href="#CD004865-tbl-0001">Table 1</a> Transfusion guidelines). </p> <div class="table" id="CD004865-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Transfusion guidelines</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Indications for transfusion followed slightly modified criteria described in a previous study (<a href="./references#CD004865-bbs2-0021" title="ShannonKM , KeithJF3rd , MentzerWC , EhrenkranzRA , BrownMS , WidnessJA , et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight infants. Pediatrics1995;95:1‐8. ">Shannon 1995</a>).<br/> The transfusion criteria were:<br/> A) Hct 0.31‐0.35; Receiving &gt; 35% supplemental hood oxygen; Intubated on CPAP or mechanical ventilation with mean airway pressure &gt; 6 to 8 cm water<br/> B) Hct 0.21‐0.30; Receiving &lt; 35% supplemental hood oxygen; On CPAP or mechanical ventilation with mean airway pressure &lt; 6 cm water; Significant apnoea and bradycardia (&gt; 9 episodes in 12 hours or 2 episodes in 24 hours requiring bag and mask ventilation) while receiving therapeutic doses of methylxanthines; Heart rate &gt;180 beats/min or respiratory rate &gt; 80 breaths/min persisting for 24 hours; Weight gain &lt; 10 g/day observed over four days while receiving &gt; 100 kcal/kg/day; Undergoing surgery<br/> C) Hct &lt; 21%; Asymptomatic with reticulocytes &lt; 1%<br/> D) Transfuse at any Hct value if hypovolaemic shock develops<br/> E) Do not transfuse: to replace blood removed for laboratory tests; For low Hct alone. Patients were transfused with packed red blood cells at 15 mL/kg, administered in 2 ‐3 hours. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants on assisted ventilation or &gt; 40% of inspired oxygen were not transfused unless Hct dropped below 0.40. Spontaneously breathing infants were not transfused unless Hct dropped below 0.35 during the first 2 weeks of life, 0.30 during the 3rd to 4th weeks, and 0.25 thereafter. Transfusion was allowed when life threatening anaemia or hypovolaemia was diagnosed by the treating neonatologist, or surgery was planned. Twelve of the 14 centres used satellite packs of the original red cell pack to reduce donor exposure. The amount of packed red cells transfused was not reported. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CPAP = continuous positive airway pressure<br/> Hct = haematocrit </p> </div> </div> <p><a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>: This was a blinded multicentre randomised placebo‐controlled study conducted in seven private hospitals in Buenos Aires, Argentina between July 1996 to October 1997. </p> <p> <ul id="CD004865-list-0003"> <li> <p>Objective: To evaluate whether early treatment (day two to three of life) with EPO in preterm infants with birthweight &lt; 1250 g 1) decreases the number of transfusions during the first two weeks of life; and 2) is more effective than late treatment (day 15) to decrease the total transfusion requirement. </p> </li> <li> <p>Population: Infants with a birthweight &lt; 1250 g and a gestational age &lt; 32 weeks. Infants were excluded if they had major congenital malformations, chromosomal anomalies, haemolytic and/or haemorrhagic disease, intrauterine infections, systemic hypertension, and neutropenia (absolute neutrophil count &lt; 1.5x10<sup>9</sup>/L). No infant was excluded based on severity of illness. </p> </li> <li> <p>Intervention: In the early EPO group, infants received EPO 1250 IU/kg/week (high dose) intravenously (iv) from day two to day 14 of life; in the late EPO group, infants received placebo during this time period. Subsequently, all infants received EPO 750 IU/kg/week (high dose) subcutaneously (sc) for six additional weeks. All infants were given oral iron 6 mg/kg/day as ferrous sulphate (high dose), starting as soon as enteral feedings were initiated and continuing during the entire treatment period as well as folic acid. </p> </li> <li> <p>Outcomes assessed: Number of transfusions during the first two weeks of life and the total transfusion requirement per infant. Other outcomes included use of one ore more RBC transfusions, mortality during hospital stay, intraventricular haemorrhage (grade III/IV), weight gain, ROP (during the study period and among infants examined during the first year of life) and sudden infant death syndrome (SIDS). </p> </li> </ul> </p> <p><a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>: This was a blinded multicentre randomised placebo‐controlled study conducted in 14 centres in four European countries (Belgium, France, Germany, Switzerland) between May 1998 to June 1999. An early EPO, a late EPO and a control group were studied. The early EPO and late EPO groups were eligible for inclusion in this review. </p> <p> <ul id="CD004865-list-0004"> <li> <p>Objective: To investigate whether EPO reduces the need for transfusion in ELBW infants and to determine the optimal time for treatment. </p> </li> <li> <p>Population: Infants with a birthweight between 500 to 999 g were eligible. Infants were excluded prior to randomisation if they had cyanotic heart disease, major congenital malformation requiring surgery, mother had received an investigational drug during pregnancy, gestational age &gt; 30 completed weeks or lack of consent. </p> </li> <li> <p>Intervention: In the early EPO group infants received 750 IU/kg/week of EPO (high dose) from the first week of life for nine weeks. In the late EPO group, infants received the same treatment three weeks later (high dose). Treatment in both groups continued until days 65 to 68 of life. EPO was given iv in both groups as long as the infant had an iv line in place and sc thereafter. The late EPO group (until EPO was given) received sham‐injections. Enteral iron 3 mg/kg was given to all infants from days three to five (low dose) and was increased at days 12 to 14 to 6 mg/kg/day (high dose) and to 9 mg/kg/day at days 24 to 26 of life (high dose). </p> </li> <li> <p>Outcomes assessed: The primary outcome was no transfusion and haematocrit levels never below 30%. Other outcomes included use of one ore more RBC transfusions, mean number of transfusions per infant, volume of red cells transfused (ml/kg/day), mortality during hospital stay, NEC, IVH (grade III/IV), PVL, ROP, BPD, length of hospital stay). </p> </li> </ul> </p> </section> <section id="CD004865-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Neither of the two trials provided information on how the random sequence was generated. Both included studies (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>; <a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) were randomised double‐blind controlled studies with concealed allocation. Donato et al. (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) report that infants were assigned to one of the two groups at birth through a central randomisation process. Placebo and EPO were indistinguishable before and after reconstitution. Parents, investigators, and nurses were unaware of each patient's treatment group. Maier et al. (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) concealed the allocation by means of numbered sealed envelopes. To assure blinding and to avoid placebo injections, sham injections were given to the late EPO group prior to starting treatment with EPO. In both studies, outcomes were assessed by individuals unaware of treatment assignment. Sample size calculations were performed in both studies. Six infants with significant protocol violations were excluded from the study by Donato et al (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>). The group assignment was not reported, but it is likely that the excluded infants were equally distributed between the groups as 57 infants remained in each group. In the study by Maier et al (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>), no infant was withdrawn from the early EPO and late EPO groups. Follow‐up was complete for the study by Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>), but not in the study by Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>). (See Table <a href="./references#CD004865-sec-0075" title="">Characteristics of included studies</a>). Both studies were industry funded (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>; <a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>). We obtained unpublished data from the authors of both studies. </p> </section> <section id="CD004865-sec-0058"> <h3 class="title" id="CD004865-sec-0058">Effects of interventions</h3> <section id="CD004865-sec-0059"> <h4 class="title">Early (zero to seven days) versus late (eight to 28 days) initiation of EPO (Comparison 01): </h4> <p><b>PRIMARY OUTCOME:</b> </p> <p><b><i>Outcome 1,1: Use of one or more red blood cell transfusions</i> </b> (<a href="#CD004865-fig-0001">Figure 1</a>) </p> <div class="figure" id="CD004865-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.1 Use of one or more red blood cell transfusions." data-id="CD004865-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.1 Use of one or more red blood cell transfusions. </p> </div> </div> </div> <p>Both studies reporting on 262 infants assessed the use of one or more red blood cell transfusions. Neither found a significant effect. The meta‐analysis did not find a significant effect [typical risk ratio (RR) 0.91 (95% confidence interval (CI) 0.78 to 1.06); typical risk difference (RD) ‐0.07 (95% CI ‐0.18 to 0.04)]. This result was consistent across the two studies.There was no heterogeneity for RR or RD (0%).<br/> <br/> <b><i>SECONDARY OUTCOMES:</i> </b> </p> <p><b><i>Outcome 1.2.1 and 1.2.2: The total volume (mL/kg) of red blood cells transfused per infant</i> </b> </p> <p>Donato et al (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) reported on this outcome in 144 infants. They did not find a significant effect [mean difference (MD) 0.30 mL/kg (95% CI ‐13.04 to 13.64)].<br/> We obtained unpublished data from Maier et al. (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>). They reported on the volume of red blood cells transfused in 148 infants in mL/kg/day. They did not find a significant effect [MD ‐0.80 mL/kg/day (95% CI ‐1.88 to 0.28)]. Test for heterogeneity not applicable. </p> <p><b><i>Outcome 1.3: Number of red blood cell transfusions per infant</i> </b> </p> <p>Both studies reporting on 262 infants assessed the number of red blood cell transfusions per infant. Neither found a significant effect. The meta‐analysis did not find a significant effect [typical MD ‐0.32, 95% CI ‐0.92 to 0.29)]. This result was consistent across studies. There was no heterogeneity for this outcome (0%). </p> <p><b><i>Outcome 1.4: Number of donors to whom the infant was exposed</i> </b> </p> <p>Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported on this outcome in 148 infants. They did not find a significant effect [MD ‐0.20; (95% CI ‐0.67 to 0.27)]. Test for heterogeneity not applicable. </p> <p><b><i>Outcome 1.5: Mortality during initial hospital stay (all causes)</i> </b><br/> <br/> Both studies reporting on 262 infants assessed mortality during initial hospital stay. Neither found a significant effect. The meta‐analysis did not find a significant effect [typical RR 0.76 (95% CI 0.39 to 1.51); RD ‐ 0.03, (95% CI ‐0.11 to 0.05)]. This result was consistent across studies. There was no heterogeneity for RR or RD (0%). </p> <p><b><i>Outcome 1.6: Retinopathy of prematurity (ROP) (all stages)</i> </b> (<a href="#CD004865-fig-0002">Figure 2</a>) </p> <div class="figure" id="CD004865-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.6 Retinopathy of prematurity (all stages)." data-id="CD004865-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.6 Retinopathy of prematurity (all stages). </p> </div> </div> </div> <p>We obtained unpublished data from both lead authors of the studies included in this review for this outcome. Both studies assessed ROP in a total of 191 infants. Donato et al reported on the rate of ROP in infants examined during the first year of life. Maier et al reported on the worst stage of ROP during the study. There was a significant increase in the incidence of ROP (all stages) in the study by Donato et al (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>), but not in the study by Maier et al (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>). The meta‐analysis found a significant effect [typical RR 1.40 (95% CI 1.05 to 1.86); typical RD 0.16 (95% CI 0.03 to 0.29); number needed to harm (NNTH); 6 (95% CI 3 to 33)].There was high heterogeneity for this outcome (RR P = 0.007; I<sup>2</sup> = 86%; RD P = 0.02; I<sup>2</sup> = 81%). </p> <p><b><i>Outcome 1.7: Retinopathy of prematurity (stage &gt; 3)</i> </b> </p> <p>We obtained unpublished data from both lead authors of the studies included in this review for this outcome. Both studies assessed this outcome in a total of 191 infants. Donato et al reported on the rate of ROP in infants examined during the first year of life. Maier et al reported on the worst stage of ROP during the study. Neither found a significant effect. The meta‐analysis did not find a significant effect [typical RR 1.56 (95% CI 0.71 to 3.41); typical RD 0.05 (95% CI ‐0.04 to 0.14). This result was consistent across studies.There was no heterogeneity for RR or RD (0%). </p> <p><b><i>Proven sepsis (Clinical symptoms and signs of sepsis and positive blood culture) (No outcome table)</i> </b>. </p> <p>No data for this outcome were reported</p> <p><b><i>Outcome 1.8 Necrotising enterocolitis (NEC) (Bell's stage II or more)</i> </b> </p> <p>Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported on this outcome in 148 infants. The study did not find a significant effect [RR 1.00 (95% CI 0.37 to 2.71); RD 0.00 (95% CI ‐0.09 to 0.09)].<br/> <br/> <b><i>Outcome 1.9.1: Intraventricular haemorrhage (IVH); grades III and IV</i> </b><br/> <br/> Both studies (n = 262) reported on the incidence of IVH grade III and IV. Neither found a significant effect. The meta‐analysis did not find a significant effect [typical RR 1.33 (95% CI 0.84 to 2.13); typical RD 0.06 (95% CI ‐0.04 to 0.16)]. There was no heterogeneity for RR or RD (0%). The results were consistent across studies. </p> <p><b><i>Outcome 1.10: Periventricular leukomalacia (PVL); cystic changes in the periventricular areas</i> </b> </p> <p>Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported on PVL in 148 infants. The study did not find a significant effect for RR [RR 0.09 (95% CI 0.01, 1.62)]; but for RD [RD ‐0.07 (95% CI ‐0.13 to ‐0.01)]; number needed to benefit (NNTB) = 14 (95% CI 8 to 100). Test for heterogeneity not applicable. </p> <p><b><i>Length of hospital stay (No outcome table)</i> </b> </p> <p>Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported on the length of hospital stay. The median (quartiles) number of days in hospital was 87 days (73 to 107) in the early EPO group and 90 days (68 to 110) in the late group. There was no statistically significant difference (P = 0.94) across three groups including a control group (87 days; 69 to 108). </p> <p><b><i>Outcome 1.11: Bronchopulmonary dysplasia (BPD) (supplementary oxygen at 28 days of age or at 36 weeks postmenstrual age and compatible X‐ray)</i> </b><br/> <br/> Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported on the need for oxygen at 36 weeks postmenstrual age in 148 infants. The study did not find a significant effect [RR 0.90 (95% CI 0.53 to 1.54); RD ‐0.03 (95% ‐0.17 to 0.12). Test for heterogeneity not applicable. </p> <p><b><i>Outcome 1.12: Sudden infant death after discharge</i> </b><br/> <br/> Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) reported no deaths in either group after a follow‐up period of nine to 24 months after discharge. </p> <p><b><i>Long‐term outcomes assessed at any age beyond one year of age by a validated cognitive, motor, language, or behavioural/school/social interaction/adaptation test (No outcome table).</i> </b><br/> <br/> No data for these outcomes were reported. </p> <p><b><i>Neutropenia</i> (<i>No outcome table)</i> </b> </p> <p>Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) reported that the incidence of neutropenia was similar in the two groups, but did not provide any data. Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) reported that neutrophil counts did not differ between groups, but did not provide any data. </p> <p><b><i>Any side effects reported in the trials (No outcome table)</i> </b> </p> <p>Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) stated "No clinical adverse effect attributable to EPO, oral iron, or folic acid administration was observed". </p> <p><b><i>Outcome 1.13: Weight gain during the study period (This outcome was not included in the protocol for this review)</i> </b><br/> <br/> In the study by Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>), the MD for weight gain during the entire study period was 6.0 g (95% CI ‐137.37 to 149.37) comparing the early EPO group to the late EPO group. In the study by Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>), the median weight gain was 890 g in the early EPO group and 872 g in the late EPO group during the first nine weeks of life. Quartiles were not provided. </p> <p><b><i>Outcome 1.14: Thrombocytosis (This outcome was not included in the protocol for this review)</i> </b><br/> <br/> Donato (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>) reported on thrombocytosis (platelet count &gt; 500 x 10<sup>9</sup>/L) in 114 infants. The study did not show a significant effect [RR 1.06 (95% CI 0.61 to 1.84); RD 0.02 (95% CI ‐0.15 to 0.19)]. </p> <p>In the study by Maier (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) the median increase in platelet count during the study was 118 x 10<sup>9</sup>/L in the early EPO group, 155x10<sup>9</sup>/L in the late EPO group and 186 x 10<sup>9</sup>/L in the control group. A P value was not reported. </p> <p><b>Subgroup analyses</b> </p> <p>We planned subgroup analyses within this review for low (&lt; 500 IU/kg/week) and high (&gt; 500 IU/kg/week) doses of EPO, and low (&lt; 5 mg/kg/day) and high (&gt; 5 mg/kg/day) doses of supplemental iron administered by any route. However, both included studies used high dose of EPO and high dose of iron, and therefore, subgroup analyses were not performed. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004865-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004865-sec-0060"></div> <p>The main objective of this review was to assess whether early versus late treatment with EPO would reduce the need for one or more red blood cell transfusions. Two high quality placebo‐controlled, multicentre trials conducted in Argentina and in four European countries were identified for this review. These two studies included a total of 262 preterm infants with very low/extremely low birth weight, who were enrolled at approximately three days of age. The dose of EPO varied from 750 to 1250 IU/kg/week (high dose). All infants received supplemental iron (high dose). Both studies used well defined, although not identical, criteria for red blood cell transfusions (see Additional table; <a href="#CD004865-tbl-0001">Table 1</a> Transfusion guidelines). In the study by Maier et al (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>), more than 30% of the enrolled infants had received red blood transfusions prior to study entry. In the study by Donato et al (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>), 14% had received red blood cell transfusions prior to enrolment. </p> <p>Early treatment with EPO did not significantly reduce the risk for an infant of receiving a red blood cell transfusion compared with late treatment. There was no statistically significant heterogeneity for this or any of the other effectiveness outcomes of interest, justifying the combination of the results from the two studies when possible. There was no significant reduction in the number of transfusions per infant nor in the number of donors to whom the infant was exposed. </p> <p>The results for other secondary outcomes included in this review reached statistical significance only for periventricular leukomalacia (PVL) and retinopathy of prematurity (ROP). PVL was reported in one study (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>). There was a statistically significant reduction for risk difference (RD) but not for risk ratio (RR) (there was no case of PVL in the early EPO group). We consider this finding of borderline statistical significance. </p> <p>A total of 191 infants of 268 infants enrolled were assessed for ROP (all stages, and stage &gt; 3). The lack of outcome ascertainment in a large number of infants is of concern. There was a statistically significant increased risk of ROP (any stage reported). The typical RR was 1.45 (95% CI 1.08 to 1.95), the typical RD was 0.18 (95% CI 0.05 to 0.31) and the number needed to harm (NNTH) was six (95% CI 3 to 20). There was statistically significant (high) heterogeneity for this outcome. The heterogeneity is likely at least in part due to differences in the rates of ROP and the different times in the life of the infants when ROP was assessed. There were no striking differences in the dose of EPO or iron used in the two studies. The transfusion guidelines were most strict in the study by Donato et al (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>). It is possible that there were differences in many aspects of care between Argentina and the four countries enrolling infants in Europe. These differences may have contributed to the differences in rates of ROP. The outcome of ROP (stage &gt; 3) was assessed in the same population as all stages of ROP. The meta‐analysis did not find a significant effect [typical RR 1.56 (95% CI 0.71 to 3.41); typical RD 0.05 (95% CI ‐0.04 to 0.14)]. This result was consistent across studies. There was no heterogeneity for this outcome. The increased risk of ROP is of concern. The results are similar to the Cochrane review of "Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" (<a href="./references#CD004865-bbs2-0019" title="OhlssonA , AherSM . Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2] ">Ohlsson 2006</a>) (updated in 2012). No other important neonatal adverse outcomes or side effects were noted. </p> <p>The results of this systematic review should be considered in conjunction with our other two Cochrane reviews (both updated in 2012) that have been conducted "Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" (<a href="./references#CD004865-bbs2-0019" title="OhlssonA , AherSM . Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2] ">Ohlsson 2006</a>) and "Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" (<a href="./references#CD004865-bbs2-0004" title="AherS , OhlssonA . Late erythropoietin for preventing red blood cell transfusion. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004868.pub2] ">Aher 2006a</a>). In our review of "Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" (<a href="./references#CD004865-bbs2-0019" title="OhlssonA , AherSM . Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2] ">Ohlsson 2006</a>), we noted an increased risk of ROP. Based on current evidence, an increased risk of developing ROP with early EPO cannot be excluded. For detailed discussion of the potential association with ROP and EPO, please refer to the Cochrane review of "Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants" (<a href="./references#CD004865-bbs2-0019" title="OhlssonA , AherSM . Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2] ">Ohlsson 2006</a>) that was updated in 2012. </p> <p>Other systematic reviews of EPO do not address the issue of early versus late treatment. The trials included in this review (<a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a>; <a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>) were not included in the meta‐analyses by Vamvakas et al (<a href="./references#CD004865-bbs2-0025" title="VamvakasEC , StraussRG . Meta‐analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion2001;41:406‐15. ">Vamvakas 2001</a>) and Garcia et al (<a href="./references#CD004865-bbs2-0009" title='GarciaMG , HutsonAD , ChristensenRD . Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta‐analysis. Journal of Perinatology2002;22:108‐11. '>Garcia 2002</a>). Kotto‐Kome et al (<a href="./references#CD004865-bbs2-0015" title='Kotto‐KomeAC , GarciaMG , CalhounDA , ChristensenRD . Effect of beginning recombinant erythropoietin treatment within the first week of life, among very‐low‐birth‐weight neonates, on "early" and "late" erythrocyte transfusions: a meta‐analysis. Journal of Perinatology2004;24:24‐9. '>Kotto‐Kome 2004</a>) included both trials in their meta‐analysis of the effect of early EPO on early and late erythrocyte transfusions, but did not compare the effectiveness of early versus late EPO administration. None of these meta‐analyses included analyses on the incidence of ROP. </p> <p>Early treatment with EPO did not confer any major benefits compared with late EPO treatment. The major obstacle to reduce any donor exposure during the hospital stay is that as many as one third of these infants will require a red blood cell transfusion prior to the initiation of treatment with EPO. In the study by Maier et al (<a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a>), 12 of the 14 centres used satellite packs of the original red cell pack to reduce donor exposure in both groups. The use of satellite packs and conservative transfusion guidelines reduces the exposure to multiple donors during the hospitalisation for preterm infants. </p> <p>It is unlikely that long‐acting EPO [Aranesp (Darbepopoietin alfa, Amgen)] would confer any benefits with regards to any donor exposure, but could reduce the number of injections the infant would require (<a href="./references#CD004865-bbs2-0018" title="OhlsRK , DaiA . Long‐acting erythropoietin: clinical studies and potential uses in neonates. Clinics in Perinatology2004;31:77‐89. ">Ohls 2004</a>). To date, only a dose finding trial has been published (<a href="./references#CD004865-bbs2-0026" title="WarwoodTL , OhlsRK , WiedmeierSE , LambertDK , JonesC , ScoffieldSH , et al. Single‐dose darbepoetin administration to anemic preterm neonates. Journal of Perinatology2005;25:725‐30. ">Warwood 2005</a>). The authors concluded, based on pharmacodynamic and pharmacokinetic findings, that darbepoetin dosing in neonates would require a higher unit dose/kg and a shorter dosing interval than are generally used for anaemic adults (<a href="./references#CD004865-bbs2-0026" title="WarwoodTL , OhlsRK , WiedmeierSE , LambertDK , JonesC , ScoffieldSH , et al. Single‐dose darbepoetin administration to anemic preterm neonates. Journal of Perinatology2005;25:725‐30. ">Warwood 2005</a>). </p> <p>Administration of EPO could potentially have a neuroprotective effect in preterm infants, especially in infants with perinatal asphyxia (<a href="./references#CD004865-bbs2-0007" title="DameC , JuulSE , ChristensenRD . The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate2001;79:228‐35. ">Dame 2001</a>; <a href="./references#CD004865-bbs2-0014" title="JuulS . Erythropoietin in the central nervous system, and its use to prevent hypoxic‐ischemic brain damage. Acta Paediatrica Supplement2002;91:36‐42. ">Juul 2002</a>). This aspect of EPO use will be systematically reviewed separately (<a href="./references#CD004865-bbs2-0028" title="YuZ , GuoX , HanS , LuJ , SunQ , OhlssonA . Erythropoietin for term and later preterm infants with hypoxicischemic encephalopathy (protocol). Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD008316] ">Yu 2010</a>). </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD004865-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.1 Use of one or more red blood cell transfusions." data-id="CD004865-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.1 Use of one or more red blood cell transfusions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.6 Retinopathy of prematurity (all stages)." data-id="CD004865-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Early (0‐7 days) vs. late (8‐28 days) initiation of EPO, outcome: 1.6 Retinopathy of prematurity (all stages). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 1 Use of one or more red blood cell transfusions." data-id="CD004865-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 1 Use of one or more red blood cell transfusions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 2 Total volume of red blood cells transfused per infant." data-id="CD004865-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 2 Total volume of red blood cells transfused per infant. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 3 Number of red blood cell transfusions per infant." data-id="CD004865-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 3 Number of red blood cell transfusions per infant. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 4 Number of donors the infant was exposed to." data-id="CD004865-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 4 Number of donors the infant was exposed to. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 5 Mortality during initial hospital stay (all causes)." data-id="CD004865-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 5 Mortality during initial hospital stay (all causes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 6 Retinopathy of prematurity (all stages)." data-id="CD004865-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 6 Retinopathy of prematurity (all stages). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 7 Retinopathy of prematurity (stage &gt;/= 3)." data-id="CD004865-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 7 Retinopathy of prematurity (stage &gt;/= 3). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 8 NEC." data-id="CD004865-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 8 NEC. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 9 IVH." data-id="CD004865-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 9 IVH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 10 PVL." data-id="CD004865-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 10 PVL. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 11 BPD (oxygen at 36 weeks)." data-id="CD004865-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 11 BPD (oxygen at 36 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 12 Sudden infant death after discharge." data-id="CD004865-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 12 Sudden infant death after discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 13 Weight gain (grams) during the study period (from entry to exit from study)." data-id="CD004865-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 13 Weight gain (grams) during the study period (from entry to exit from study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004865-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/urn:x-wiley:14651858:media:CD004865:CD004865-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_t/tCD004865-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 14 Thrombocytosis (platelet count &gt; 500 x 10 9/L)." data-id="CD004865-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Early (0‐7 days) versus late (8‐28 days) initiation of EPO, Outcome 14 Thrombocytosis (platelet count &gt; 500 x 10 <sup>9</sup>/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/media/CDSR/CD004865/image_n/nCD004865-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD004865-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Transfusion guidelines</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reference</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indications</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004865-bbs2-0001" title="DonatoH , VainN , RendoP , VivasN , PrudentL , LarguiaM , et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo‐controlled, multicenter trial. Pediatrics2000;105:1066‐72. ">Donato 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Indications for transfusion followed slightly modified criteria described in a previous study (<a href="./references#CD004865-bbs2-0021" title="ShannonKM , KeithJF3rd , MentzerWC , EhrenkranzRA , BrownMS , WidnessJA , et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight infants. Pediatrics1995;95:1‐8. ">Shannon 1995</a>).<br/> The transfusion criteria were:<br/> A) Hct 0.31‐0.35; Receiving &gt; 35% supplemental hood oxygen; Intubated on CPAP or mechanical ventilation with mean airway pressure &gt; 6 to 8 cm water<br/> B) Hct 0.21‐0.30; Receiving &lt; 35% supplemental hood oxygen; On CPAP or mechanical ventilation with mean airway pressure &lt; 6 cm water; Significant apnoea and bradycardia (&gt; 9 episodes in 12 hours or 2 episodes in 24 hours requiring bag and mask ventilation) while receiving therapeutic doses of methylxanthines; Heart rate &gt;180 beats/min or respiratory rate &gt; 80 breaths/min persisting for 24 hours; Weight gain &lt; 10 g/day observed over four days while receiving &gt; 100 kcal/kg/day; Undergoing surgery<br/> C) Hct &lt; 21%; Asymptomatic with reticulocytes &lt; 1%<br/> D) Transfuse at any Hct value if hypovolaemic shock develops<br/> E) Do not transfuse: to replace blood removed for laboratory tests; For low Hct alone. Patients were transfused with packed red blood cells at 15 mL/kg, administered in 2 ‐3 hours. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004865-bbs2-0002" title="MaierRF , ObladenM , Muller‐HansenI , KattnerE , MerzU , ArlettazR , et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics2002;141:8‐15. ">Maier 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Infants on assisted ventilation or &gt; 40% of inspired oxygen were not transfused unless Hct dropped below 0.40. Spontaneously breathing infants were not transfused unless Hct dropped below 0.35 during the first 2 weeks of life, 0.30 during the 3rd to 4th weeks, and 0.25 thereafter. Transfusion was allowed when life threatening anaemia or hypovolaemia was diagnosed by the treating neonatologist, or surgery was planned. Twelve of the 14 centres used satellite packs of the original red cell pack to reduce donor exposure. The amount of packed red cells transfused was not reported. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CPAP = continuous positive airway pressure<br/> Hct = haematocrit </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Transfusion guidelines</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/full#CD004865-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004865-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early (0‐7 days) versus late (8‐28 days) initiation of EPO</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Use of one or more red blood cell transfusions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.78, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total volume of red blood cells transfused per infant <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Total volume of red blood cells transfused (mL/kg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐13.04, 13.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Total volume of red cells transfused (mL/kg/day)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.88, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of red blood cell transfusions per infant <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.92, 0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of donors the infant was exposed to <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.67, 0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality during initial hospital stay (all causes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.39, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Retinopathy of prematurity (all stages) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.05, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity (stage &gt;/= 3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.71, 3.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 NEC <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.37, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 IVH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.84, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Grade III/IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.84, 2.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 PVL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 BPD (oxygen at 36 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.53, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Sudden infant death after discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Weight gain (grams) during the study period (from entry to exit from study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.00 [‐137.37, 149.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Thrombocytosis (platelet count &gt; 500 x 10 <sup>9</sup>/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.61, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early (0‐7 days) versus late (8‐28 days) initiation of EPO</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004865.pub4/references#CD004865-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004865.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004865-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004865-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD004865-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004865-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004865-note-0002">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004865-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004865\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004865\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004865\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004865\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004865\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QO4KtYGW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004865.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004865.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004865.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004865.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004865.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728131281"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004865.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728131285"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004865.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ebcff6fc7f498',t:'MTc0MDcyODEzMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 